XML 22 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Cash Flows
$ in Thousands
12 Months Ended
Jun. 30, 2020
USD ($)
Jun. 30, 2019
USD ($)
Jun. 30, 2018
USD ($)
Cash flows from operating activities:      
Net income $ 185,221 $ 186,182 $ 288,862
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 7,163 7,398 9,338
Amortization of deferred financing costs 1,994 3,003 3,003
Debt refinancing expense 455 0 0
Share-based compensation expense 19,235 18,087 13,979
Provision for doubtful accounts 278 930 17
Change in assets and liabilities:      
Accounts receivable, net 2,582 1,371 (5,391)
Related party receivables, net 1,840 (3,984) 4,800
Prepaid expenses and other assets (7,129) 4,464 1,398
Accounts payable 82 (553) 219
Related party payables, including payable to MSGS and MSGE 531 277 (2,171)
Prepaid/payable for income taxes 2,148 (9,294) 10,165
Accrued and other liabilities (3,377) 364 (2,168)
Deferred revenue 2,568 (4,441) (445)
Deferred income taxes (3,559) 2,155 (110,996)
Net cash provided by operating activities 210,032 205,959 210,610
Cash flows from investing activities:      
Capital expenditures (2,814) (2,879) (3,724)
Investment in nonconsolidated entity 0 (2,000) 0
Net cash used in investing activities (2,814) (4,879) (3,724)
Cash flows from financing activities:      
Principal repayments on term loan facilities (see Note 7) (35,000) (175,000) (125,000)
Proceeds from senior secured credit facilities (see Note 7) 100,000 0 0
Payments for financing costs 3,983 0 0
Payments for Repurchase of Common Stock (293,531) 0 (13,850)
Taxes paid in lieu of shares issued for share-based compensation (4,290) (5,000) (3,780)
Net cash used in financing activities (236,804) (180,000) (142,630)
Net increase (decrease) in cash and cash equivalents (29,586) 21,080 64,256
Cash and Cash Equivalents [Abstract]      
Cash $ 196,837 $ 226,423 $ 205,343